tirzepatide surpass 4 Effects of versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial SURPASS-5: Tirzepatide lowers HbA1c in

This new study finds that, within this group, people with heart failure did just as well as people without in terms of the outcomes we measured

Shes on her last box of Wegovy injections

food quality Semaglutide reduces appetite, but it doesnt automatically fix food choices

Tissues were labeled numerally for unbiased analysis

Metabolism Conditions like fatty liver disease, diabetes, and high blood sugar can make weight loss more complex because there is already some level of metabolic dysfunction, says Dr

The body adapts to lower calorie intake, and continued loss requires either dose increases, intensified lifestyle changes, or both